Table: begin end state 1 20 cytoplasmic 21 41 transmembrane 42 47 non-cytoplasmic 48 70 transmembrane 71 91 cytoplasmic 92 114 transmembrane 115 126 non-cytoplasmic 127 144 transmembrane 145 154 cytoplasmic 155 176 transmembrane 177 195 non-cytoplasmic 196 215 transmembrane 216 235 cytoplasmic 236 255 transmembrane 256 290 non-cytoplasmic 291 312 transmembrane 313 332 cytoplasmic 333 353 transmembrane 354 361 non-cytoplasmic 362 383 transmembrane 384 394 cytoplasmic 395 413 transmembrane 414 419 non-cytoplasmic 420 443 transmembrane 444 449 cytoplasmic
Input: >AO353_27910 MEIEEFGYKQELKRSLSLTDLVVYGMIFMIPIAPFGVYGYVNQEAPGMVPLAYIIGMVAM LFTALSYGSMARAFPIAGSVYSYAQRGLHPHVGFIAGWLMLLDYLLIPPLLYVYAAMALN HLYPDIPKVGFILAFLVSATFVNLRGITFTARMNIIFLLAQLVVLGIFLFYAWTALHGGA GNGQLTLAPLYNPEHFNFALLMQAVSIAVLSFLGFDAISTLAEEIKGDPGRSVGKAALIT LVVMGVIFVVQTWIATDLAAGMGFKSADTAFYEIAEIAAGSWLATVTGVATALAWGVAVA ITSQAAVSRLLFGMARDGKLPKVLAKVHPKHNTPYISIYLVAVLSLLICYLFINSVDTLT SLVNFGALSGFILLHLTVINYYWRRQKSGQLIRHLVCPVIGFIIVSAILYNMGVDAQKLG GIWIAAGLVYLFFLNRIGASAVLPAPSNS
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server